Strata Critical Medical, Inc.
SRTAUS売上高
$197M
百万USD
営業利益
$-22M
百万USD
純利益
$41M
百万USD
ROE
14.8%
最新FY
EPS
$0.50
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | - | $-1M | - |
| FY2021 | Q3 | $13M | $-24M | - |
| FY2021 | FY | $51M | $-40M | $-0.93 |
| FY2022 | Q1 | $27M | $-11M | $-0.16 |
| FY2022 | Q2 | $36M | $8M | $0.10 |
| FY2022 | Q3 | $46M | $-9M | $-0.13 |
| FY2022 | FY | $146M | $-27M | $-0.38 |
| FY2023 | Q1 | $45M | $-10M | $-0.14 |
| FY2023 | Q2 | $61M | $-12M | $-0.17 |
| FY2023 | Q3 | $71M | $0M | $0.00 |
| FY2023 | FY | $225M | $-56M | $-0.76 |
| FY2024 | Q1 | $52M | $-4M | $-0.06 |
| FY2024 | Q2 | $68M | $-11M | $-0.15 |
| FY2024 | Q3 | $75M | $-2M | $-0.03 |
| FY2024 | FY | $249M | $-27M | $-0.35 |
| FY2025 | Q1 | $54M | $-3M | $-0.04 |
| FY2025 | Q2 | $71M | $-4M | $-0.05 |
| FY2025 | Q3 | $49M | $57M | $0.70 |
| FY2025 | FY | $197M | $41M | $0.50 |
| FY2026 | Q1 | $67M | $2M | $0.03 |
財務データ
| 指標 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $51M | $146M | $225M | $249M | $197M |
| 営業利益 | - | $-1M | $-24M | $-54M | $-68M | $-34M | $-22M |
| 純利益 | - | $-21M | $-40M | $-27M | $-56M | $-27M | $41M |
| 総資産 | $278M | $278M | $343M | $325M | $295M | $257M | $325M |
| 純資産 | - | - | - | - | - | - | - |
| 自己資本 | $5M | $5M | $291M | $274M | $234M | $222M | $279M |
| 営業CF | - | $-1M | $-16M | $-37M | $-32M | $-3M | $-49M |
| EPS | - | - | $-0.93 | $-0.38 | $-0.76 | $-0.35 | $0.50 |
| BPS | - | - | $4.13 | $3.81 | $3.11 | $2.78 | $3.21 |
| ROE | - | -410.4% | -13.8% | -9.9% | -23.9% | -12.3% | 14.8% |